Restasis and Juxtapid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Juxtapid (lomitapide mesylate). Common drug interactions include weight decreased among females and abnormal dreams among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Juxtapid. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Juxtapid?

Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.



On Jul, 12, 2026

14 people who take Restasis and Juxtapid together, and have interactions are studied.

Restasis and Juxtapid drug interactions.

What are the common drug interactions of Restasis and Juxtapid, by gender? *:

female:

  1. Weight decreased
  2. Low density lipoprotein increased (cholesterol increased in blood)
  3. Dyspepsia (indigestion)
  4. Drug ineffective
  5. Impaired gastric emptying
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Muscle spasms (muscle contraction)
  9. Alanine aminotransferase increased
  10. Aspartate aminotransferase increased

male:

  1. Abnormal dreams
  2. Arthralgia (joint pain)
  3. Depression
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Hunger
  7. Influenza like illness
  8. Memory impairment
  9. Myalgia (muscle pain)

What are the common drug interactions of Restasis and Juxtapid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abnormal dreams
  2. Arthralgia (joint pain)
  3. Depression
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Hunger
  7. Influenza like illness
  8. Memory impairment
  9. Myalgia (muscle pain)

60+:

  1. Weight decreased
  2. Low density lipoprotein increased (cholesterol increased in blood)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Feeling hot
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Weight fluctuation
  10. Abdominal discomfort

What are the existing conditions these people have? *

  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 21.43%
  2. Migraine (headache): 3 people, 21.43%
  3. High Blood Pressure: 3 people, 21.43%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Juxtapid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Restasis and Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restasis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Juxtapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine and lomitapide mesylate (the active ingredients of Restasis and Juxtapid, respectively), and Restasis and Juxtapid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: